Understanding and Assessing the Patient Experience of Symptoms for Polycystic Liver Disease (PLD): Development of a New Disease-Specific Symptom Patient-Reported Outcome Measure (PROM)
Author(s)
Brod M1, Pfeiffer KM1, Waldman LT1, Olevik A2, Axling U2, Johnsson M2
1The Brod Group, Mill Valley, CA, USA, 2Camurus AB, Lund, Sweden
Presentation Documents
OBJECTIVES: PLD is a rare condition in which multiple cysts develop in the liver. Approximately 20% of patients experience a high symptom burden. Limited patient-centered research exists for this condition, and much of the patient-reported data results from generic measures. To address this gap, a disease-specific PROM, the PLD-Symptom was developed.
METHODS: A non-interventional, qualitative study following FDA guidelines was conducted. Data were collected from the literature and individual telephone interviews, following semi-structured interview guides, with 4 clinical experts and 30 adult respondents (United States and United Kingdom). Information was coded based on adapted grounded theory. A draft theoretical model of PLD signs/symptoms and draft items were generated, underwent translatability assessment, and were cognitive debriefed (n=12) employing “think aloud” methodology.
RESULTS: Respondents were mostly female (77%), average age 51.2 (range, 32-72), 67% had polycystic kidney disease, and average time to initial diagnosis 8.5 years (range, 0-25). Experts (3 hepatologists, 1 nurse) identified 21 symptoms in total. All but 3 of these were also reported by respondents who reported 40 symptoms in total. Saturation (95%) was reached by the 19th interview. Symptoms most frequently reported included bloating (n=27, 90%), abdominal/stomach pain (n=26, 87%), tired/low energy (n=25, 83%), and abdominal/stomach increase (n=25, 83%). Symptoms were included in the draft measure if endorsed by at least 40% of participants (or 35-39% if high conceptual importance), rated bothersome by most respondents, experienced at least once a week by most respondents, potentially responsive to treatment, and proximal symptoms. Eleven symptoms met criteria for inclusion. Cognitive debriefing resulted in a validation-ready, 10-item measure. All final items and instructions were found to be relevant, understandable, and consistent with the intended meaning.
CONCLUSIONS: The PLD-Symptom can be considered to have strong content validity based on the concept elicitation data. Psychometric validation is now needed to confirm measurement properties.
Conference/Value in Health Info
Value in Health, Volume 26, Issue 6, S2 (June 2023)
Code
PCR8
Topic
Patient-Centered Research
Topic Subcategory
Instrument Development, Validation, & Translation, Patient-reported Outcomes & Quality of Life Outcomes
Disease
Rare & Orphan Diseases